Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,212 recruiting studies in this area right now.
By phase
- Not applicable9,534
- Phase 24,410
- Phase 12,676
- Phase 1/Phase 21,654
- Phase 31,395
- Phase 2/Phase 3284
- Phase 4259
Top conditions
- Breast Cancer1,200
- Prostate Cancer645
- Cancer633
- Colorectal Cancer479
- Lung Cancer418
- Ovarian Cancer338
- Multiple Myeloma329
- Pancreatic Cancer290
- Gastric Cancer282
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor247
- Advanced Solid Tumor233
- Cervical Cancer226
- Head and Neck Cancer226
- Endometrial Cancer210
- Advanced Solid Tumors203
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University302
- National Cancer Institute (NCI)293
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- City of Hope Medical Center145
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences142
- AstraZeneca133
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,413
- Texas635
- Arizona507
- Florida436
- Alabama428
- New York405
- Massachusetts341
- Maryland329
- New Jersey272
- Pennsylvania231
Recruiting studies20,212 total
- NCT07384416RecruitingPhase 2
Investigational drug plus lenvatinib for penile cancer that has been treated before
This trial tests a combination of two drugs, QL1706 and lenvatinib, in people with penile cancer that has already been treated with other therapies. The goal is to see if this new combination can shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18–80 - NCT07386704Enrolling by invitationPhase 2
Nimotuzumab with chemo and radiation for advanced pancreatic cancer
This trial tests adding nimotuzumab (a targeted antibody) to standard chemoradiation for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this combination can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–80 - NCT07387666RecruitingEarly Phase 1
Imaging a common drug in glioblastoma
This trial uses a special imaging technique to see how the drug Acetadote (often used for acetaminophen overdose) behaves in glioblastoma tumors. It may help doctors learn more about the tumor and could guide future treatments.
Dallas, TexasAges 18 years+ - NCT07381075RecruitingPhase 2
New drug combo before surgery for head and neck cancer
This trial tests a new drug (antibody-drug conjugate) alone or with an immunotherapy drug before surgery for head and neck cancer that can be removed. The goal is to see if this combination shrinks the tumor and improves outcomes.
Chengdu, SichuanAges 18–70 - NCT07383298Enrolling by invitation
Lower dose of olverembatinib for chronic myeloid leukemia
This study looks at whether lowering the dose of olverembatinib (from 30 or 40 mg to 20 mg every other day) keeps working well for people with chronic myeloid leukemia who have already had a good response. It aims to see if a lower dose can still control the cancer while possibly reducing side effects.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07381764RecruitingPhase 2
Rechallenge with targeted drugs for certain colorectal cancers
This study tests a new approach for people with a specific type of metastatic colorectal cancer that has stopped responding to initial treatments. It compares reusing a targeted drug combination (irinotecan plus cetuximab) versus a different chemotherapy plus a targeted drug (trifluridine/tipiracil plus bevacizumab) to see which works better for patients whose tumors have a certain genetic profile.
AlessandriaAges 18 years+ - NCT07381985Enrolling by invitation
Managing hereditary cancer risk in rural areas
This study tests a way to help people with inherited cancer gene mutations manage their health, especially if they live in rural areas. You join if you found out about the mutation more than a year ago.
Burlington, VermontAges 18 years+ - NCT07382791Recruiting
Stomach emptying after pancreas surgery
This study looks at how the stomach empties after pancreas surgery. It aims to understand and possibly help with slow stomach emptying, a common issue after this operation.
Taipei, TaiwnAges 20–75 - NCT07382817RecruitingPhase 1
A study of CAR T cells for patients with certain T or NK cell cancers
This trial tests whether a new treatment, called CAR T cells that target CD94, can help people with specific types of T or NK cell lymphoma or leukemia that have not responded to other treatments or have come back. The goal is to see if it is safe and works against the cancer.
Houston, TexasAges 18 years+ - NCT07382557Recruiting
Lung cancer screening decision aid for high-risk patients
This study tests a tool to help people decide about lung cancer screening. It is for current or former smokers who have a family history of smoking and lung cancer.
Houston, TexasAges 50–80 - NCT07385001RecruitingPhase 1/Phase 2
Ivonescimab with chemotherapy before surgery for esophageal cancer
This trial tests a new drug called Ivonescimab (AK112) combined with two chemotherapy drugs (Abraxane and cisplatin) given before surgery for esophageal cancer. The goal is to see if this combination can shrink tumors and improve surgery outcomes for patients with locally advanced disease.
Xi'an, ShannxiAges 18–75 - NCT07388771Recruiting
Predicting treatment results for lung cancer before surgery
This trial is testing a treatment given before surgery for non-small cell lung cancer. Patients receive chemotherapy plus immunotherapy (chemo-immunotherapy) first, then have surgery to remove the tumor. The goal is to see how well this approach works.
Wuhan, HubeiAges 18 years+ - NCT07384884Recruiting
Surgery and laser for glioblastoma on both sides
This study tests a treatment for glioblastoma that affects both sides of the brain. It combines surgery to remove as much tumor as possible with a laser treatment (LITT) to destroy the smaller tumor on the other side.
LondonAges 18–80 - NCT07381179Recruiting
Sharing wisdom and hope with illness
This study invites people with a long-term illness to record their stories and wisdom. You can bring a caregiver if you want. It's about giving hope and sharing experiences.
Rochester, MinnesotaAges 18 years+ - NCT07381972RecruitingPhase 3
Light and sound therapy for nodular skin cancer
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
Jaú, São PauloAges 18 years+ - NCT07380698Recruiting
ICG dose and storage for lymph node mapping in gynecologic cancer
This trial looks at how the dose and storage of a dye called indocyanine green (ICG) affects its ability to find sentinel lymph nodes during surgery for gynecologic cancers like cervical, endometrial, and vulvar cancer. The goal is to make the procedure both more effective and more affordable.
AdanaAges Any age - NCT07381959Recruiting
Brain injury markers in children with brain tumors
This study looks at markers of brain injury in children with brain tumors who have or have not received radiation therapy, compared to healthy children. It aims to better understand how treatments affect the brain.
UppsalaAges Up to 17 years - NCT06493370RecruitingPhase 2
IV vitamin C plus chemo for bladder cancer
This trial tests adding high-dose vitamin C (ascorbate) to a standard chemotherapy combination for people with muscle-invasive bladder cancer who cannot take or choose not to take cisplatin. The goal is to find a more affordable and effective treatment option.
Iowa City, IowaAges 18 years+ - NCT06816914RecruitingPhase 2
Perioperative chemo for resectable pancreatic cancer
This trial tests a combination of chemotherapy drugs (liposomal irinotecan with fluorouracil, leucovorin, and oxaliplatin) given before and after surgery for pancreatic cancer that can be fully removed. It aims to see if this approach improves outcomes for patients with stage I or II disease.
Kaohsiung CityAges 20–75 - NCT06827899RecruitingPhase 2
New combination therapy for older adults with untreated leukemia
This trial tests a three-drug combination (venetoclax, chidamide, and azacitidine) followed by another combination (decitabine plus MAG) for older adults with untreated acute myeloid leukemia (AML) who cannot have standard chemotherapy. It aims to offer a gentler but effective treatment option.
Xiamen, FujianAges 60 years+ - NCT06836492RecruitingPhase 3
Risk-based treatment study for children with rhabdomyosarcoma
This study tests different treatment plans for children with rhabdomyosarcoma based on their individual risk factors. It aims to find the best therapy for each child, potentially improving outcomes.
Guangzhou, GuangdongAges birth–18 years - NCT06836219Recruiting
Study of treatment outcomes based on HRD status in advanced ovarian cancer
This study looks at how women with advanced ovarian cancer respond to treatments based on whether their tumors have a specific DNA repair problem called homologous recombination deficiency (HRD). It aims to understand which treatments work best for different HRD test results.
Bari, BAAges 18 years+ - NCT05000827Recruiting
PSMA PET scan to guide lymph node surgery in prostatectomy
This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.
Nijmegen, GelderlandAges 18 years+ - NCT05303714RecruitingPhase 3
PIPAC plus chemo for limited peritoneal stomach cancer
This trial tests a treatment called PIPAC (medicine delivered into the abdomen through a small scope) along with “multimodal” therapy, including chemotherapy, for stomach cancer that has spread only in the lining of the abdomen in limited amounts. It may help control the cancer and prevent progression after surgery.
VeronaAges 18–75
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,212 recruiting oncology studies from the U.S. registry right now, out of 30,394 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.